Gene Editing Revolution: Molecular Biology, CRISPR Systems

Trace the shift from ancient selective breeding to modern molecular tools, including recombinant dna, insulin production, and transgenic crops, toward the Crispr era of surgical gene editing.

Explore restriction enzymes as molecular scissors that create blunt or sticky ends, enabling recombinant DNA with DNA ligase and plasmids, followed by transformation in bacteria to express the gene.

Zinc finger nucleases enable programmable gene editing by combining a DNA binding domain with a DNA cutting enzyme, designed in left and right pairs to create targeted double-strand breaks.

Talens are the second generation programmable gene editors inspired by Xanthomonas proteins, combining a DNA-binding repeat region with a FokI nuclease to induce precise one-base-per-repeat double-strand breaks.

Compare zinc finger nucleases and TALENs, first-generation editing tools that use different DNA recognition. Show how zinc fingers recognize three bases and TALENs single bases, noting delivery and cloning implications.

Explore how bacteria and archaea use CRISPR as an adaptive immune system, storing viral memories with spacers, expressing crRNA, and guiding Cas proteins to cut invading DNA.

Discover how the Cas9 protein and guide RNA form a programmable ribonucleoprotein that targets DNA near a PAM, enabling double-strand breaks for gene editing.

Learn how the protospacer adjacent motif guides Cas9 to target DNA, with SpCas9 seeking ngg near the seed region, enabling precise gene editing while avoiding off-target risks.

Cas9 creates a blunt double-strand break with two nuclease domains near pam sequence; CS 12 variants may yield staggered cuts and repair via end-joining or template guidance by seed pairing.

Learn how cells choose between nhej and hdr to repair dna breaks, determine knockouts versus precise gene insertions, and how researchers tilt the balance with templates and cell-cycle control.

Base editing uses a deactivated Cas9 fused to a deaminase to swap single nucleotides without cutting DNA. It targets a 4–5 base window for precise C-to-T and A-to-G edits.

Prime editing delivers precise DNA edits without double-strand breaks, using a Cas9 nickase–reverse transcriptase fusion and pegRNA for insertions, deletions, and base-to-base conversions.

Explore CRISPR interference and activation to turn gene expression up or down without DNA cutting, enabling epigenetic editing with dCas9 and KRAB or VP64 at promoters.

Leverage viral vectors to deliver CRISPR inside target cells by engineering safe vehicles like AAV and lentivirus, addressing cargo limits, immune challenges, and scalable production.

Discover non-viral CRISPR delivery with lipid nanoparticle and electroporation, explaining how cargo is protected, delivered to the cytoplasm, and concentrated in the liver, with lab-based and microinjection options.

Compare somatic and germline gene editing to explain targeting of body tissues and embryos, permanence across generations, and ethical debates around consent, safety, and designer babies.

Apply CRISPR to monogenic diseases by editing single genes. Use ex vivo and in vivo approaches, from sickle cell and cystic fibrosis to transthyretin amyloidosis.

Explore how crispr enables precise, fast edits to crops for drought, heat, and disease resistance, healthier foods, and reduced waste, while examining the controversial, high-stakes potential of gene drives.

Explore off-target effects in CRISPR-Cas9, where mismatches can trigger unintended cuts and cancer risks, and learn to predict with silico tools and verify with circle seq and HiFi Cas9.

Apply the four ethical pillars—autonomy, beneficence, non-maleficence, and justice—to gene editing decisions. Navigate irb review, informed consent, and regulatory pathways to safeguard safety, access, and biosecurity in crispr therapies.